Dusza SW - Search Results

1

Impact of dermatologic adverse events on quality of life in 283 cancer patients: a questionnaire study in a dermatology referral clinic.

Rosen AC, Case EC, Dusza SW, Balagula Y, Gordon J, West DP, Lacouture ME. Rosen AC, et al. Among authors: dusza sw. Am J Clin Dermatol. 2013 Aug;14(4):327-33. doi: 10.1007/s40257-013-0021-0. Am J Clin Dermatol. 2013. PMID: 23625802

2

Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.

Agero AL, Dusza SW, Benvenuto-Andrade C, Busam KJ, Myskowski P, Halpern AC. Agero AL, et al. Among authors: dusza sw. J Am Acad Dermatol. 2006 Oct;55(4):657-70. doi: 10.1016/j.jaad.2005.10.010. J Am Acad Dermatol. 2006. PMID: 17010747 Review.

3

The CASH (color, architecture, symmetry, and homogeneity) algorithm for dermoscopy.

Henning JS, Dusza SW, Wang SQ, Marghoob AA, Rabinovitz HS, Polsky D, Kopf AW. Henning JS, et al. Among authors: dusza sw. J Am Acad Dermatol. 2007 Jan;56(1):45-52. doi: 10.1016/j.jaad.2006.09.003. J Am Acad Dermatol. 2007. PMID: 17190620

4

Randomized double-blind trial of prophylactic oral minocycline and topical tazarotene for cetuximab-associated acne-like eruption.

Scope A, Agero AL, Dusza SW, Myskowski PL, Lieb JA, Saltz L, Kemeny NE, Halpern AC. Scope A, et al. Among authors: dusza sw. J Clin Oncol. 2007 Dec 1;25(34):5390-6. doi: 10.1200/JCO.2007.12.6987. J Clin Oncol. 2007. PMID: 18048820 Clinical Trial.

5

A prospective randomized trial of topical pimecrolimus for cetuximab-associated acnelike eruption.

Scope A, Lieb JA, Dusza SW, Phelan DL, Myskowski PL, Saltz L, Halpern AC. Scope A, et al. Among authors: dusza sw. J Am Acad Dermatol. 2009 Oct;61(4):614-20. doi: 10.1016/j.jaad.2009.03.046. Epub 2009 Jul 31. J Am Acad Dermatol. 2009. PMID: 19646778 Clinical Trial.

6

Safety of retinyl palmitate in sunscreens: a critical analysis.

Wang SQ, Dusza SW, Lim HW. Wang SQ, et al. Among authors: dusza sw. J Am Acad Dermatol. 2010 Nov;63(5):903-6. doi: 10.1016/j.jaad.2010.07.015. Epub 2010 Aug 7. J Am Acad Dermatol. 2010. PMID: 20692724 No abstract available.

7

The significance of crystalline/chrysalis structures in the diagnosis of melanocytic and nonmelanocytic lesions.

Balagula Y, Braun RP, Rabinovitz HS, Dusza SW, Scope A, Liebman TN, Mordente I, Siamas K, Marghoob AA. Balagula Y, et al. Among authors: dusza sw. J Am Acad Dermatol. 2012 Aug;67(2):194.e1-8. doi: 10.1016/j.jaad.2011.04.039. Epub 2011 Oct 24. J Am Acad Dermatol. 2012. PMID: 22030020 Free article.

8

Dermoscopic features of basal cell carcinomas: differences in appearance under non-polarized and polarized light.

Liebman TN, Jaimes-Lopez N, Balagula Y, Rabinovitz HS, Wang SQ, Dusza SW, Marghoob AA. Liebman TN, et al. Among authors: dusza sw. Dermatol Surg. 2012 Mar;38(3):392-9. doi: 10.1111/j.1524-4725.2011.02205.x. Epub 2011 Oct 31. Dermatol Surg. 2012. PMID: 22093161

9

Recognition of melanoma: a dermatologic clinical competency in medical student education.

Goulart JM, Dusza S, Pillsbury A, Soriano RP, Halpern AC, Marghoob AA. Goulart JM, et al. J Am Acad Dermatol. 2012 Oct;67(4):606-11. doi: 10.1016/j.jaad.2011.12.007. Epub 2012 Jan 24. J Am Acad Dermatol. 2012. PMID: 22281164

10

Clinical and dermoscopic characteristics of desmoplastic melanomas.

Jaimes N, Chen L, Dusza SW, Carrera C, Puig S, Thomas L, Kelly JW, Dang L, Zalaudek I, Braun RP, Menzies SW, Busam KJ, Marghoob AA. Jaimes N, et al. Among authors: dusza sw. JAMA Dermatol. 2013 Apr;149(4):413-21. doi: 10.1001/jamadermatol.2013.2248. JAMA Dermatol. 2013. PMID: 23325288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

236 results

Search Page

Filters